Vendor, Plan-Les-Ouates, CHE
Institut De Formulation Des Vaccins (Ch) SA
UEI N773KSZMJA78, CAGE SMVP9
2 awards and $8,308,093 obligated between June 25, 2024 and September 14, 2026, 100% under full and open competition, against 18.5 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Computer Systems Design ServicesNAICS 541512 | $6,744,317 |
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $1,563,776 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93023C00048Definitive Contract, June 25, 2024, Full and Open Competition, 24 offers | National Institutes of Health NiaidNational Institutes of Health | Advanced Development of LQ a Liposome-Based Saponin-Containing Adjuvant for Use in Pansarbecovirus VaccinesNAICS 541512, PSC AN12 | $6,744,317 |
| 75N93024C00021Definitive Contract, September 19, 2024, Full and Open Competition, 13 offersSolicitation | National Institutes of Health NiaidNational Institutes of Health | Vaccine Adjuvant Discovery ProgramNAICS 541714, PSC AN12 | $1,563,776 |
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 9 across 2 awards